sulbactam has been researched along with Pneumonia, Bacterial in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.76) | 18.2507 |
| 2000's | 17 (40.48) | 29.6817 |
| 2010's | 18 (42.86) | 24.3611 |
| 2020's | 5 (11.90) | 2.80 |
| Authors | Studies |
|---|---|
| Docobo-Pérez, F; Domínguez-Herrera, J; García-Curiel, A; Jiménez, L; Jiménez-Mejias, ME; López-Rojas, R; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C | 1 |
| Keam, SJ | 1 |
| Gao, W; Lu, H; Wang, H; Wu, G; Yang, C; Yuan, C | 1 |
| Chen, L; Deng, Y; Lv, Q; Ruan, J; Zhu, X | 1 |
| Nozawa, K; Sato, H; Sato, VH; Sugiyama, E; Suzuki, H; Suzuki, T; Tajima, M; Takahashi, K; Yoshii, M | 1 |
| Djubailo, AV; Fatenkov, OV; Kuzmina, TM; Rubanenko, OA; Svetlova, GN | 1 |
| Carter, JM; Dorner, RA; Fajardo, M; Fricchione, M; Higgins, A; Marsden, L; Ryan, E | 1 |
| Du, L; Long, Y; Shi, H; Shi, L; Sun, L; Wang, H; Xu, H; Zhen, Y; Zhu, J; Zou, B | 1 |
| Abdollahi, A; Beigmohammadi, MT; Doomanlou, M; Khalili, H; Mohammadi, M; Shojaei, L | 1 |
| Chen, YH; Chen, YS; Chuang, YC; Huang, CT; Ko, WC; Lee, WS; Lin, HH; Lin, JC; Liu, JW; Liu, YC; Lu, MC; Tang, HJ; Wang, FD | 1 |
| Fujita, J; Higa, F; Hiramatsu, K; Kadota, J; Kohno, S; Tateyama, M; Tokimatsu, I; Yamamoto, Y; Yanagihara, K | 1 |
| Marshall, S; Muto, C; Shoji, S; Soto, E; Tomono, Y | 1 |
| Fang, X; Gong, M; Xia, J; Xu, Y; Zhang, D; Zhou, Y | 1 |
| Ikawa, K; Matsumoto, K; Morikawa, N; Nakamura, K; Shigemi, A; Takeda, Y; Ueno, K; Umezaki, Y; Watanabe, E; Yokoyama, Y | 1 |
| Babarina, MB; Sanadze, AG; Sokolova, VI; Sychev, DA; Zaĭkov, DA | 1 |
| Beloborodova, ÉI; Beloborodova, EV; Cherniavskaia, GM; Chernogoriuk, GÉ; Denisova, OA; Iakimenko, IuV; Strezh, IuA; Topol'nitskiĭ, EB; Vil'danova, LR | 1 |
| Itamura, R; Kadota, J; Kohno, S; Mikamo, H; Niki, Y; Tateda, K | 1 |
| Cheng, CW; Hsu, PC; Huang, CT; Lee, MH; Leu, HS; Lin, HS; Ye, JJ | 1 |
| Çilli, A; Karaboğa, B | 1 |
| Huang, CT; Huang, PY; Lee, MH; Lin, HS; Wu, YM; Yang, CC; Ye, JJ; Yeh, CF | 1 |
| Higashiyama, Y; Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Nakamura, S; Seki, M; Tashiro, T; Yamamoto, Y; Yanagihara, K | 1 |
| Belet, N; Çiftçi, E; Doğru, Ü; Ince, E; Özdemir, H; Tapısız, A | 1 |
| Docobo-Pérez, F; García-Curiel, A; Ibáñez-Martínez, J; Jiménez-Mejias, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C | 1 |
| Absi, R; Arenoso, H; Bantar, C; Bustos, JL; Curcio, D; Franco, D; Izaguirre, M; Jasovich, A; Larrateguy, L; Mastruzzo, M; Mobilia, L; Morera, G; Oliva, ME; Prieto, S; Soutric, J; Vesco, E | 1 |
| Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
| Asaoka, N; Fujita, K; Honda, N; Kurihara, T; Nakamura, J; Ohba, H; Okimoto, N | 1 |
| Mitrokhin, SD | 1 |
| Perederko, LV; Polikarpova, SV; Postnikov, SS; Semykin, SIu | 1 |
| Marinella, MA | 1 |
| Mukonin, AA; Ovsiankin, AV | 1 |
| Huang, JJ; Yu, JL; Zeng, Q | 1 |
| Docobo-Pérez, F; Fernández-Cuenca, F; Pachón, J; Pachón-Ibáñez, ME; Pascual, A | 1 |
| Fukuda, Y; Higashiyama, Y; Hirakata, Y; Izumikawa, K; Kohno, S; Miyazaki, Y; Mizuta, Y; Seki, M; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
| Sinopal'nikov, AI; Zaĭtsev, AA | 1 |
| Barcelona, L; Marín, M; Stamboulian, D | 1 |
| Cepparulo, M; Ciliberti, G; Dal Farra, F; Ghelfi, R; Guelfi, R; Mancuso, I; Paris, R; Pirica, P; Pirina, P; Serra, G; Todisco, T | 1 |
| Betrosian, AP; Douzinas, EE; Frantzeskaki, F; Xanthaki, A | 1 |
| Chifu, S; Ebihara, M; Fukunaga, H; Furuno, T; Genka, K; Harada, Y; Hiraoka, T; Hirota, N; Inuyama, M; Ishibashi, T; Iwanaga, T; Kisanuki, K; Kishikawa, R; Makie, T; Matsukizono, K; Matsuura, Y; Mitsuno, T; Namba, K; Oe, T; Shimazu, K; Sugiyama, M; Takamoto, M; Tsumori, Y; Tsurutani, H; Ueno, Y | 1 |
| Maeda, S; Maeda, T; Nakamura, H; Yamada, Y | 1 |
| Arenoso, HJ; Bantar, C; Blanco, M; Fernandez Canigia, L; Jasovich, A; Montoto, M; Nicola, F; Smayevsky, J; Soutric, J | 1 |
| Boucher, BA; Croce, MA; Fabian, TC; Hanes, SD; Wood, GC | 1 |
2 review(s) available for sulbactam and Pneumonia, Bacterial
| Article | Year |
|---|---|
Sulbactam/Durlobactam: First Approval.
Topics: Acinetobacter baumannii; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Sulbactam | 2023 |
[Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Sulbactam | 2008 |
17 trial(s) available for sulbactam and Pneumonia, Bacterial
| Article | Year |
|---|---|
Effectiveness of Cefoperazone-sulbactam alone and Combined with Tigecycline in the Treatment of Multi-drug Resistant Acinetobacter Baumannii Pulmonary Infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cefoperazone; China; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sulbactam; Tigecycline; Treatment Outcome | 2020 |
Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam | 2018 |
Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cefoperazone; Drug Therapy, Combination; Female; Haemophilus Infections; Healthcare-Associated Pneumonia; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas Infections; Sulbactam; Treatment Outcome | 2019 |
Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
Topics: Administration, Oral; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Injections, Intravenous; Japan; Male; Middle Aged; Pneumonia, Bacterial; Recurrence; Sulbactam; Treatment Outcome | 2013 |
Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Computer Simulation; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Female; Humans; Infusions, Intravenous; Japan; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pneumonia, Bacterial; Sulbactam | 2014 |
Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacteria; Community-Acquired Infections; Female; Humans; Japan; Male; Middle Aged; Pneumonia, Bacterial; Sputum; Sulbactam; Treatment Outcome; Young Adult | 2015 |
A clinical comparative study of piperacillin and sulbactam/ampicillin in patients with community-acquired bacterial pneumonia.
Topics: Aged; Aged, 80 and over; Ampicillin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperacillin; Pneumonia, Bacterial; Prospective Studies; Radiography; Sulbactam | 2009 |
Efficacy of amoxicillin-sulbactam, given twice-a-day, for the treatment of community-acquired pneumonia: a clinical trial based on a pharmacodynamic model.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sulbactam; Time Factors; Treatment Outcome | 2002 |
[Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Treatment Outcome | 2003 |
[Clinical and bacteriological substantiation of the use of cefoperazone/sulbactam in complex therapy of patients with pyo-destructive forms of lower respiratory tract infection (LRTI)].
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sulbactam | 2004 |
[Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children].
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Pneumonia, Bacterial; Sulbactam | 2005 |
Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia.
Topics: Age Factors; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Cilastatin; Community-Acquired Infections; Drug Combinations; Female; Humans; Imipenem; Male; Pneumonia, Bacterial; Prospective Studies; Protease Inhibitors; Severity of Illness Index; Sulbactam; Treatment Outcome | 2006 |
[Clinical and pharmacoeconomic perspective use of amoxicillin/sulbactam in the treatment of extra-hospital pneumonia].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Sulbactam | 2006 |
An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Sulbactam | 2008 |
Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam | 2008 |
[Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Ampicillin; Aspartate Aminotransferases; Cefotiam; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Pneumonia, Bacterial; Sulbactam; Treatment Outcome | 1998 |
Efficacy of antibiotics against influenza-like illness in an influenza epidemic.
Topics: Acute Disease; Ampicillin; Bacterial Infections; Child, Preschool; Diarrhea; Disease Outbreaks; Drug Therapy, Combination; Female; Fever; Humans; Incidence; Influenza A virus; Influenza, Human; Japan; Male; Otitis Media; Pneumonia, Bacterial; Population Surveillance; Sulbactam; Urban Health | 1999 |
23 other study(ies) available for sulbactam and Pneumonia, Bacterial
| Article | Year |
|---|---|
Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Meningitis, Bacterial; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rabbits; Rifampin; Sulbactam; Treatment Outcome | 2010 |
Sulbactam/durlobactam (Xacduro) for Acinetobacter pneumonia.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Sulbactam | 2023 |
Case report: Mycobacterium monacense isolated from the blood culture of a patient with pulmonary infection.
Topics: Adult; Blood Culture; Cefoperazone; China; DNA, Ribosomal; Humans; Linezolid; Male; Mycobacterium; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Sulbactam; Voriconazole | 2020 |
Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Computer Simulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Injections, Intravenous; Male; Pneumonia, Bacterial; Renal Elimination; Retrospective Studies; Sulbactam; Treatment Outcome | 2021 |
[Community acquired bacterial pneumonia and comorbidity in elderly patients].
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Comorbidity; Female; Heart Failure; Humans; Male; Pneumonia, Bacterial; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Sulbactam | 2017 |
Gradenigo Syndrome and Cavitary Lung Lesions in a 5-Year-Old With Recurrent Otitis Media.
Topics: Abducens Nerve Diseases; Actinomycosis; Ampicillin; Anti-Bacterial Agents; Child, Preschool; Coinfection; Diagnosis, Differential; Fatigue; Fusobacterium Infections; Fusobacterium nucleatum; Gram-Positive Bacterial Infections; Humans; Male; Mastoiditis; Otitis Media; Peptostreptococcus; Pneumonia, Bacterial; Recurrence; Sulbactam; Syndrome; Trigeminal Neuralgia; Weight Loss | 2017 |
Effects of specific egg yolk immunoglobulin on pan-drug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Cefoperazone; Dexamethasone; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Egg Yolk; Enzyme-Linked Immunosorbent Assay; Immunoglobulins; Injections, Intraperitoneal; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Sulbactam; Tumor Necrosis Factor-alpha | 2017 |
A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Thienamycins | 2014 |
Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.
Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Female; Lung; Mice; Microbial Sensitivity Tests; Microbial Viability; Plasma; Pneumonia, Bacterial; Sulbactam; Thigh | 2014 |
[Treatment approaches for bronchopulmonary infection in myasthenia gravis patients].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchopneumonia; Cefoperazone; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Myasthenia Gravis; Pneumonia, Bacterial; Sulbactam; Treatment Outcome | 2014 |
[A case of thoracic actinomycosis].
Topics: Actinomyces; Actinomycosis; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections; Sulbactam; Treatment Outcome | 2014 |
Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Taiwan; Time Factors | 2015 |
[Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia].
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Length of Stay; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Sulbactam | 2015 |
Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Taiwan; Tigecycline; Treatment Outcome | 2016 |
Ampicillin/sulbactam for children hospitalized with community-acquired pneumonia.
Topics: Adolescent; Ampicillin; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Infant; Male; Multivariate Analysis; Odds Ratio; Pneumonia, Bacterial; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Sulbactam; Treatment Failure; Turkey | 2011 |
Efficacy of rifampin, in monotherapy and in combinations, in an experimental murine pneumonia model caused by panresistant Acinetobacter baumannii strains.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Imipenem; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Pneumonia, Bacterial; Rifampin; Rodent Diseases; Sulbactam; Treatment Outcome | 2011 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly.
Topics: Aged; Aged, 80 and over; Ampicillin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Sulbactam | 2003 |
[Sulperazone in the treatment of severe infections in patients with cancer].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Neoplasms; Pneumonia, Bacterial; Sulbactam; Surgical Wound Infection; Urinary Tract Infections | 2003 |
Community-acquired pneumonia due to Pasteurella multocida.
Topics: Aged; Ampicillin; Animals; Anti-Bacterial Agents; Cats; Community-Acquired Infections; Dogs; Humans; Male; Pasteurella Infections; Pasteurella multocida; Pneumonia, Bacterial; Sulbactam; Zoonoses | 2004 |
Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Imipenem; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Pneumonia, Bacterial; Rifampin; Sulbactam | 2006 |
Rationale for treating community-acquired lower respiratory tract infections with amoxicillin/sulbactam combination through pharmacodynamic analysis in the setting of aminopenicillin-resistant organisms.
Topics: Administration, Oral; Adult; Amoxicillin; Community-Acquired Infections; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Pneumonia, Bacterial; Serum Bactericidal Test; Streptococcus pneumoniae; Sulbactam | 2001 |
Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.
Topics: Acinetobacter; Adult; Ampicillin; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Treatment Outcome; Ventilators, Mechanical | 2002 |